These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11245273)

  • 41. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiostatin: a negative regulator of endothelial-dependent vasodilation.
    Koshida R; Ou J; Matsunaga T; Chilian WM; Oldham KT; Ackerman AW; Pritchard KA
    Circulation; 2003 Feb; 107(6):803-6. PubMed ID: 12591747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor.
    Babaei S; Teichert-Kuliszewska K; Monge JC; Mohamed F; Bendeck MP; Stewart DJ
    Circ Res; 1998 May; 82(9):1007-15. PubMed ID: 9598598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.
    Kane AJ; Barker JE; Mitchell GM; Theile DR; Romero R; Messina A; Wagh M; Fraulin FO; Morrison WA; Stewart AG
    Br J Pharmacol; 2001 Apr; 132(8):1631-8. PubMed ID: 11309233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin therapy and angiogenesis.
    Skaletz-Rorowski A; Walsh K
    Curr Opin Lipidol; 2003 Dec; 14(6):599-603. PubMed ID: 14624137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
    Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle.
    Milkiewicz M; Hudlicka O; Brown MD; Silgram H
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H336-43. PubMed ID: 15734877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.
    Pyriochou A; Vassilakopoulos T; Zhou Z; Papapetropoulos A
    Life Sci; 2007 Nov; 81(21-22):1549-54. PubMed ID: 17945311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
    Bikfalvi A; Bicknell R
    Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
    Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
    Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of protein kinase Calpha prevents endothelial cell migration and vascular tube formation in vitro and myocardial neovascularization in vivo.
    Wang A; Nomura M; Patan S; Ware JA
    Circ Res; 2002 Mar; 90(5):609-16. PubMed ID: 11909826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle.
    Toyoshima H; Nasa Y; Hashizume Y; Koseki Y; Isayama Y; Kohsaka Y; Yamada T; Takeo S
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):543-51. PubMed ID: 9781922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
    Hamsa TP; Kuttan G
    Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
    Díaz-Troya S; Najib S; Sánchez-Margalet V
    Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitric oxide as a mediator of parasympathetic vasodilation in ocular and extraocular tissues in the rabbit.
    Nilsson SF
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2110-9. PubMed ID: 8814150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.